Resources

I-MAK’s team has spent the last decade increasing transparency on patents, innovation, and access.

Briefing Memo: Risks Of The Trans-Pacific Free Trade Agreement For Access To Medicines – Analysis Of The Leaked U.S. Paper Eliminating Patent Pre-Grant Opposition

A leaked U.S. paper recently circulated to countries negotiating the TransPacific Partnership Agreement (TPPA) outlines the U.S. argument for eliminating “pre-grant opposition,” an important tool for preventing patent applicants from gaining patent monopolies based on weak or erroneous information, for improving the quality and efficiency of patent office examinations, and for safeguarding access to medicines.

Briefs & Fact Sheets 18 Jul 2011

Join us to stay updated
and help make lifesaving medicines accessible to all